Neuronal oscillations: A physiological correlate for targeting mitochondrial dysfunction in neurodegenerative diseases?

Neuropharmacology. 2016 Mar:102:48-58. doi: 10.1016/j.neuropharm.2015.10.033. Epub 2015 Oct 28.

Abstract

Increasingly in the realm of neurological disorders, particularly those involving neurodegeneration, mitochondrial dysfunction is emerging at the core of their pathogenic processes. Most of these diseases still lack effective treatment and are hampered by a shortfall in the development of novel medicines. Clearly new targets that translate well to the clinic are required. Physiological parameters in the form of neuronal network activity are increasingly being used as a therapeutic screening approach in drug development and disorders with mitochondrial dysfunction generally display neuronal network activity disturbance. However research directly linking the disturbances in neuronal network activity with mitochondrial dysfunction is only just starting to emerge. This review will summarize the breadth of knowledge linking neuronal network activity to mitochondrial dysfunction in neurodegenerative diseases and suggest potential avenues for exploration in respect to future drug development.

Keywords: Biomarker; Mitochondrial dysfunction; Neurodegenerative diseases; Neuronal oscillation; Physiological correlate.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Humans
  • Mitochondria / drug effects
  • Mitochondria / physiology*
  • Mitochondrial Diseases / drug therapy
  • Mitochondrial Diseases / physiopathology*
  • Nerve Net / drug effects
  • Nerve Net / physiopathology*
  • Neurodegenerative Diseases / drug therapy
  • Neurodegenerative Diseases / physiopathology*
  • Neurons / drug effects
  • Neurons / physiology*